Proto-oncogene expression in human glomerular diseases

被引:1
|
作者
Takemura, T
Okada, M
Akano, N
Murakami, K
Hino, S
Yagi, K
Takekoshi, Y
Yoshioka, K
机构
[1] KINKI UNIV,SCH MED,DEPT PEDIAT,SAYAMA,OSAKA 589,JAPAN
[2] HOKKAIDO UNIV,SCH MED,DEPT PEDIAT,SAPPORO,HOKKAIDO 011,JAPAN
来源
JOURNAL OF PATHOLOGY | 1996年 / 178卷 / 03期
关键词
proto-oncogene; glomerulonephritis; proliferating cell nuclear antigen; mesangial cell;
D O I
10.1002/(SICI)1096-9896(199603)178:3<343::AID-PATH481>3.0.CO;2-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of the protein products and mRNA of c-fos, c-myc, p53, and c-raf was examined in normal renal tissues and biopsy specimens from 73 patients with various glomerular diseases. Immunofluorescent staining showed that there were cell nuclei stained for c-Fos, c-Myc, and p53, and cytoplasm positive for c-Raf, in the glomeruli of patients with proliferative types of glomerulonephritis, including IgA nephritis and lupus nephritis, and in patients with focal glomerular sclerosis. Glomerular expression of c-fos and c-myc mRNA was detected by irt situ hybridization, The number of proto-oncogene-positive glomerular cells was significantly higher in lupus nephritis, IgA nephritis, and focal segmental sclerosis, as compared with minimal change nephrotic syndrome and normal specimens, In IgA nephritis, the population of glomerular cells positive for c-Fos and c-Myc and the grade of c-Raf immunoreactivity were significantly correlated with the proportion of proliferating cell nuclear antigen (PCNA)-positive glomerular cells, with histological grading of mesangial hypercellularity and matrix increase, and with the magnitude of proteinuria, These data indicate that proto-oncogene expression is associated with mesangial proliferation and matrix expansion in proliferative types of glomerulonephritis and in focal glomerular sclerosis.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [31] Human PTTG:: a new proto-oncogene family
    Prezant, TR
    Merkel, P
    Kadioglu, P
    Heaney, AP
    Horwitz, G
    Melmed, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A316 - A316
  • [32] Gene structure of the human MET proto-oncogene
    Duh, FM
    Scherer, SW
    Tsui, LC
    Lerman, MI
    Zbar, B
    Schmidt, L
    ONCOGENE, 1997, 15 (13) : 1583 - 1586
  • [33] RET proto-oncogene in the development of human cancer
    Eng, C
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 380 - 393
  • [34] EXPRESSION OF A PROTO-ONCOGENE (PROTO-MYB) IN HEMATOPOIETIC TISSUES OF MICE
    SHEINESS, D
    GARDINIER, M
    MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (07) : 1206 - 1212
  • [35] STRUCTURE OF AN ONCOGENE AND A RELATED PROTO-ONCOGENE
    WILHELMSEN, KC
    TEMIN, HM
    CLINICAL RESEARCH, 1985, 33 (04): : A936 - A936
  • [36] Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas
    Saini, Masum
    Jha, Ajaya Nand
    Abrari, Andleeb
    Ali, Sher
    BMC CANCER, 2012, 12
  • [37] Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines
    Rouzaut, A
    Recio, JA
    Notario, V
    RADIATION RESEARCH, 2001, 155 (01) : 181 - 187
  • [38] Mono-allelic expression of the Mas proto-oncogene in human breast tissue
    Miller, N
    McCann, A
    O'Connell, D
    Pedersen, IS
    Spiers, V
    Gorey, T
    Dervan, PA
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 147 - 147
  • [39] Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas
    Ferracini, R
    Olivero, M
    DiRenzo, MF
    Martano, M
    DeGiovanni, C
    Nanni, P
    Basso, G
    Scotlandi, K
    Lollini, PL
    Comoglio, PM
    ONCOGENE, 1996, 12 (08) : 1697 - 1705
  • [40] Molecular cloning and expression of proto-oncogene FRAT1 in human cancer
    Saitoh, T
    Mine, T
    Katoh, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (04) : 785 - 789